AN2 Therapeutics, Inc.
Industry: Life Sciences ・ $ANTX on Nasdaq
Insider Purchase
+$50,000
+3.81%
Shares
Shares Volume: 50,000 Shares
Average Share Price: $1
INSIDER
Easom Eric
Chief Executive Officer (Director)
reported on Nov 18 2024
traded on Nov 18 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 1,361,012 |
| PURCHASES/SALES 1Y | 1 / 1 |
| P/S VALUE RATIO | 0.896 |
| AVERAGE PURCHASE VALUE | $50,000 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 1 / 0 |
| PURCHASES/SALES 1Y | 2 / 11 |
| P/S VALUE RATIO | 0.161 |
| AVERAGE PURCHASE VALUE | $805,000 |
| COMPANY PREVIOUS TRADES |